Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06127342

Exercise and Emotional Learning in Posttraumatic Stress Disorder

The goal of this clinical trial is to test how exercise affects learning and memory processes relevant to the treatment of PTSD. Participants will complete a baseline intake followed by two experimental sessions. During the first experimental session, participants will undergo an MRI session of imaginal exposure to traumatic memory cues followed by 30-minutes of moderate intensity exercise or low intensity exercise. Participants will complete a second session of imaginal exposure with MRI 24 hours later.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky, Lexington, Kentucky, United States

Loading trial locations.

About this study

The proposed project would build on our published pilot data and animal models to demonstrate that moderate intensity physical exercise delivered after exposure therapy engages fear circuitry and enhances the consolidation of therapeutic safety learning, thereby enabling enhanced symptom reduction for PTSD. Adults with PTSD related to interpersonal violence (IPV) exposure would complete an initial session of imaginal exposure to traumatic memory cues adapted for an MRI setting. This would be followed by 30-mins of moderate intensity exercise or low intensity exercise control. Participants would return 24-hrs later to complete a second session of imaginal exposure with MRI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with PTSD related to interpersonal violence

Exclusion criteria

  • Active or recent (within the last 3 months) severe substance use disorder(s)
  • Active or recent (within the last 3 months) suicidal, psychotic, or manic symptoms/ episodes
  • Significant developmental disabilities
  • Current daily benzodiazepine or stimulant use with inability to abstain for study sessions
  • Recent changes in psychiatric medication or trauma focused cognitive-behavioral therapy (CBT) (past 4-weeks)
  • Medical condition(s) that prohibit exercise
  • History of traumatic brain injury (TBI) with loss of consciousness > 30 mins
  • Magnetic resonance imaging (MRI) contraindication(s)
  • Positive pregnancy test
  • History of seizure disorder
  • Spontaneous seizure(s) within the last 3 months

Treatment and study plan

Moderate Intensity Exercise

Behavioral

Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 5 minutes, then slowly cycle on a stationary bike for 30 minutes, then cycle on the stationary bike at a slow speed for 5 minutes.

Low Intensity Exercise

Behavioral

Participants will wear a heartrate monitor and cycle on a stationary bike at a slow speed for 40 minutes.

Primary outcomes

  1. Change in participant subjective emotional ratings

    Time frame: 24 hours

    Participant anxiety will be measured at baseline and after each imagery trial using a 10-point Likert-type scale with higher scores indicative of more subjective anxiety.

  2. Change in Heart Rate

    Time frame: 24 hours

    Participant heart rate will be measured at baseline and after each imagery trial using a Biopac MP160 system

  3. Change in Fear Circuit Blood Oxygen Level-Dependent (BOLD) Response

    Time frame: 48 hours

    Blood Oxygen Level-Dependent (BOLD) imaging will be measured during each imagery trial

Study contacts

Contact information is provided by the study sponsor or research team.

Christal G Badour, PhD

CONTACT

[email protected]

859-323-3817

Sponsors and collaborators

Lead sponsor

Christal L Badour

Other

Collaborators

  • National Institute of Mental Health (NIMH)
  • University of Texas at Austin

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Nov 13, 2023
Registry last updated
Sep 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.